Webinar | Listing Biotech Companies on the HKEX | 13 August 2024

On 13 August 2024, Julia Charlton presented a webinar on Listing Biotech Companies on the Hong Kong Stock Exchange.

This webinar covers the following topics:
− Introduction to the HKEx regime for listing pre-revenue Biotech Companies
− Chapter 18A suitability requirement under the Guide for New Listing Applicants
− Other eligibility requirements for Chapter 18A listings
− Requirements for the IPO relating to subscriptions
− Listing document disclosure requirements
− Continuing obligations of Chapter 18A issuers and requirements relating to changes to listed Biotech Companies

#BiotechIPO on #HKEX for #PreRevenueBiotech companies

Timecodes:
00:00 Introduction to the Biotech Industry and Market Dynamics
01:44 Hong Kong Stock Exchange's Biotech Listing Regime
03:30 Performance and Trends in Biotech Listings
05:25 International Biotech IPO Trends
07:08 Chapter 18A of the Main Board Listing Rules
08:54 Eligibility and Suitability for Listing
13:57 Compliance with Core Product Requirements
17:29 Third-Party Investment and Financial Requirements
25:41 Enhanced Eligibility Requirements
29:29 Public Float and Share Allocation Rules
33:01 Disclosure Requirements for Listing Documents
41:45 Financial Reporting and Regulatory Compliance
50:20 Restrictions and Regulatory Oversight
53:37 Delisting Provisions and Transition to Regular Listing

Charltons Law Firm:
https://www.charltonslaw.com/

Julia Charlton
https://www.charltonslaw.com/the-firm/people-culture/team-profile/julia-charlton/

Don’t forget to follow our social media accounts:
LinkedIn: https://linkedin.com/company/2995759/
Facebook: https://facebook.com/charltons
Instagram: https://instagram.com/charltonslaw/